设为首页 加入收藏

TOP

TRESIBA(insulin degludec injection) for subcutaneous(三十)
2016-07-04 03:01:14 来源: 作者: 【 】 浏览:12201次 评论:0

Store the Pen you are currently using out of the refrigerator below 86 OF.

Keep TRESIBA away from heat or light.

The TRESIBA FlexTouch Pen you are using should be thrown away after 56 days, even if it still has insulin left in it and the expiration date has not passed.
General Information about the safe and effective use of TRESIBA.


Keep TRESIBA FlexTouch Pens and needles out of the reach of children.

Always use a new needle for each injection.

Do not share TRESIBA FlexTouch Pens or needles with other people. You may give other people a serious infection, or get a serious infection from them.
This Instructions for Use has been approved by the U.S. Food and Drug Administration.

Manufactured by:

Novo Nordisk A/S

DK-2880 Bagsvaerd, Denmark

Revised: 09/2015

For more information go to www.TRESIBA.com

© 2015 Novo Nordisk

PRINCIPAL DISPLAY PANEL U-100(What is this?)

NDC 0169-2660-15

List: 266015

TRESIBA®

FlexTouch®

(insulin degludec injection)

For Single Patient Use Only

100 units/mL (U-100)

5×3 mL Prefilled Pens

For subcutaneous use only

Rx Only

Recommended for use with NovoFine®,
NovoFine® Plus or NovoTwist® disposable needles.

Keep in a cold place until first use.

Store at 36°F - 46°F (2°C - 8°C).

Do not freeze.

Protect from light.

PRINCIPAL DISPLAY PANEL U-200

NDC 0169-2550-13

List: 255013

TRESIBA®

FlexTouch®

(insulin degludec injection)

For Single Patient Use Only

200 units/mL (U-200)

3×3 mL Prefilled Pens

For subcutaneous use only

Rx Only

Recommended for use with
NovoFine®, NovoFine® Plus or NovoTwist®
disposable needles.

Keep in a cold place
until first use.

Store at 36°F - 46°F (2°C - 8°C).

Do not freeze.

Protect from light.

INGREDIENTS AND APPEARANCE
TRESIBA 
insulin degludec injection injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0169-2660
Route of Administration SUBCUTANEOUS
 
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
INSULIN DEGLUDEC (UNII: 54Q18076QB) (INSULIN DEGLUDEC - UNII:54Q18076QB) INSULIN DEGLUDEC 100 U  in 1 mL
 
Inactive Ingredients
Ingredient Name Strength
GLYCERIN (UNII: PDC6A3C0OX) 19.6 mg  in 1 mL
PHENOL (UNII: 339NCG44TV) 1.50 mg  in 1 mL
METACRESOL (UNII: GGO4Y809LO) 1.72 mg  in 1 mL
ZINC (UNII: J41CSQ7QDS) 32.7 ug  in 1 mL
WATER (UNII: 059QF0KO0R)  
HYDROCHLORIC ACID (UNII: QTT17582CB)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
 
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:0169-2660-15 5 in 1 CARTON  
1  3 mL in 1 SYRINGE, PLASTIC; Type 0: Not a Combination Product  
2 NDC:0169-2660-97 1 in 1 CARTON  
2  3 mL in 1 SYRINGE, PLASTIC; Type 0: Not a Combination Product  
 
 
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA203314 09/25/2015 
 
TRESIBA

以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 27 28 29 30 31 下一页 尾页 30/31/31
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇Gonal-f ® RFF* Redi-ject.. 下一篇VIBATIV(telavancin for injectio..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位